Sensitive Quantitation of Glucagon-Like Peptide-1 Analog Semaglutide in Plasma
Technical Reference Summary
Covered Models & Document Scope
Application note covering an automated LC/MS workflow for quantitation of the GLP-1 analog semaglutide (and tirzepatide MRM transitions) in human plasma using an Agilent 1290 Infinity II bio LC, Agilent 6495D triple quadrupole LC/MS, AssayMAP Bravo with RP-S cartridges, and MassHunter software; no instrument model/size variants or ordering codes are given.
Technical Data
| Parameter | Value | Condition |
|---|---|---|
| Injection volume | 5 μL p.3 ↗ | |
| LLOQ | 0.2 ng/mL p.1 ↗ | semaglutide |
| Linear range upper limit | 1,000 ng/mL p.1 ↗ | semaglutide |
| Starting material volume | 100 μL p.1 ↗ | human plasma |
| Sensitivity improvement vs organic solvent precipitation | five times p.1 ↗ | |
| Ion mode | Positive p.4 ↗ | |
| Gas temperature | 270 °C p.4 ↗ | |
| Tirzepatide precursor ion | 1,204.4 m/z p.4 ↗ | |
| Tirzepatide product ion | 396.2 m/z p.4 ↗ | |
| Tirzepatide collision energy | 26 p.4 ↗ | |
| Tirzepatide second product ion | 136.1 m/z p.4 ↗ | precursor 1,029.4 |
| Tirzepatide second collision energy | 42 p.4 ↗ | precursor 1,029.4 |
| Semaglutide precursor ion | 1,029.4 m/z p.4 ↗ | |
| Semaglutide product ion | 1,238.1 m/z p.4 ↗ | |
| Semaglutide collision energy | 30 p.4 ↗ | |
| Low QC concentration | 0.5 ng/mL p.6 ↗ | semaglutide |
| Mid QC concentration | 10.00 ng/mL p.6 ↗ | semaglutide |
| High QC concentration | 800 ng/mL p.6 ↗ | semaglutide |
| Interday % CV at LLOQ | 6.7 % p.6 ↗ | 0.2 ng/mL |
| Interday % CV at Low QC | 6.3 % p.6 ↗ | 0.5 ng/mL |
| Interday % CV at Mid QC | 8.8 % p.6 ↗ | 10.00 ng/mL |
| Interday % CV at High QC | 5.5 % p.6 ↗ | 800 ng/mL |
Operating Limits
- LLOQ: 0.2 ng/mL p.1 ↗
- Upper limit of linear calibration range: 1,000 ng/mL p.1 ↗
- Minimum starting plasma volume: 100 μL p.1 ↗